These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22563042)

  • 21. [Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements].
    Menniti-Ippolito F; Mazzanti G; Firenzuoli F; Bianchi A; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):39-42. PubMed ID: 16037648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safe drugs for children].
    Krankenpfl J; 2004; 42(7-10):230. PubMed ID: 15675392
    [No Abstract]   [Full Text] [Related]  

  • 23. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
    Cohen AL; Budnitz DS; Weidenbach KN; Jernigan DB; Schroeder TJ; Shehab N; Pollock DA
    J Pediatr; 2008 Mar; 152(3):416-21. PubMed ID: 18280852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Communicable diseases surveillance.
    Commun Dis Intell; 1997 Nov; 21(22):338-46. PubMed ID: 9409067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public perspectives on consent for the linkage of data to evaluate vaccine safety.
    Berry JG; Gold MS; Ryan P; Duszynski KM; Braunack-Mayer AJ;
    Vaccine; 2012 Jun; 30(28):4167-74. PubMed ID: 22546331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communicable Diseases Surveillance.
    Commun Dis Intell; 1998 Mar; 22(3):40-7. PubMed ID: 9557390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adverse drug reactions in childhood. A drug surveillance study in Sicily].
    Cutroneo PM; Arcoraci V; Cucinotta G; Inferrera G; Galante F; Sofia A; Ferrera E; Napolitano T; Mazzaglia G; Caputi AP
    Recenti Prog Med; 1998 Jun; 89(6):290-5. PubMed ID: 9658895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
    Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
    Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communicable diseases surveillance.
    Commun Dis Intell; 2000 Apr; 24(4):96-109. PubMed ID: 10851797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporting of adverse events following immunization in Australia.
    Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J
    J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence of adverse drug reactions in a pediatric teaching hospital: a retrospective study from 1989 to 2010].
    Huet E; Closon A; Lebel D; Durand C; Bussières JF
    Ann Pharm Fr; 2011 Nov; 69(6):317-23. PubMed ID: 22115135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of serious skin infections in New Zealand children: comparing the Tairawhiti region with national trends.
    O'Sullivan C; Baker MG; Zhang J; Davies A; Cramp G
    N Z Med J; 2012 Mar; 125(1351):40-54. PubMed ID: 22426610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standards for child and adolescent immunization practices. National Vaccine Advisory Committee.
    National Vaccine Advisory Committee
    Pediatrics; 2003 Oct; 112(4):958-63. PubMed ID: 14523192
    [No Abstract]   [Full Text] [Related]  

  • 37. Computerized surveillance for adverse drug events in a pediatric hospital.
    Kilbridge PM; Noirot LA; Reichley RM; Heard KM; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2008 Nov; ():1004. PubMed ID: 18998917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
    Budnitz DS; Pollock DA; Mendelsohn AB; Weidenbach KN; McDonald AK; Annest JL
    Ann Emerg Med; 2005 Feb; 45(2):197-206. PubMed ID: 15671977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic identification of drugs that cause birth defects--a new opportunity.
    Mitchell AA
    N Engl J Med; 2003 Dec; 349(26):2556-9. PubMed ID: 14695418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.